324 related articles for article (PubMed ID: 25100745)
1. Insulin-like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice.
Pascual-Lucas M; Viana da Silva S; Di Scala M; Garcia-Barroso C; González-Aseguinolaza G; Mulle C; Alberini CM; Cuadrado-Tejedor M; Garcia-Osta A
EMBO Mol Med; 2014 Oct; 6(10):1246-62. PubMed ID: 25100745
[TBL] [Abstract][Full Text] [Related]
2. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.
Mellott TJ; Pender SM; Burke RM; Langley EA; Blusztajn JK
PLoS One; 2014; 9(4):e94287. PubMed ID: 24732467
[TBL] [Abstract][Full Text] [Related]
3. IκB kinase/nuclear factor κB-dependent insulin-like growth factor 2 (Igf2) expression regulates synapse formation and spine maturation via Igf2 receptor signaling.
Schmeisser MJ; Baumann B; Johannsen S; Vindedal GF; Jensen V; Hvalby ØC; Sprengel R; Seither J; Maqbool A; Magnutzki A; Lattke M; Oswald F; Boeckers TM; Wirth T
J Neurosci; 2012 Apr; 32(16):5688-703. PubMed ID: 22514330
[TBL] [Abstract][Full Text] [Related]
4. Early alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease.
Pedrós I; Petrov D; Allgaier M; Sureda F; Barroso E; Beas-Zarate C; Auladell C; Pallàs M; Vázquez-Carrera M; Casadesús G; Folch J; Camins A
Biochim Biophys Acta; 2014 Sep; 1842(9):1556-66. PubMed ID: 24887203
[TBL] [Abstract][Full Text] [Related]
5. Episodic memory deficits are not related to altered glutamatergic synaptic transmission and plasticity in the CA1 hippocampus of the APPswe/PS1δE9-deleted transgenic mice model of ß-amyloidosis.
Volianskis A; Køstner R; Mølgaard M; Hass S; Jensen MS
Neurobiol Aging; 2010 Jul; 31(7):1173-87. PubMed ID: 18790549
[TBL] [Abstract][Full Text] [Related]
6. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease.
D'Amelio M; Cavallucci V; Middei S; Marchetti C; Pacioni S; Ferri A; Diamantini A; De Zio D; Carrara P; Battistini L; Moreno S; Bacci A; Ammassari-Teule M; Marie H; Cecconi F
Nat Neurosci; 2011 Jan; 14(1):69-76. PubMed ID: 21151119
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model.
Selles MC; Fortuna JTS; Zappa-Villar MF; de Faria YPR; Souza AS; Suemoto CK; Leite REP; Rodriguez RD; Grinberg LT; Reggiani PC; Ferreira ST
Mol Neurobiol; 2020 Mar; 57(3):1473-1483. PubMed ID: 31760608
[TBL] [Abstract][Full Text] [Related]
8. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
[TBL] [Abstract][Full Text] [Related]
9. Viral gene transfer of APPsα rescues synaptic failure in an Alzheimer's disease mouse model.
Fol R; Braudeau J; Ludewig S; Abel T; Weyer SW; Roederer JP; Brod F; Audrain M; Bemelmans AP; Buchholz CJ; Korte M; Cartier N; Müller UC
Acta Neuropathol; 2016 Feb; 131(2):247-266. PubMed ID: 26538149
[TBL] [Abstract][Full Text] [Related]
10. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
[TBL] [Abstract][Full Text] [Related]
11. Anti-Inflammatory Treatment with FTY720 Starting after Onset of Symptoms Reverses Synaptic Deficits in an AD Mouse Model.
Kartalou GI; Salgueiro-Pereira AR; Endres T; Lesnikova A; Casarotto P; Pousinha P; Delanoe K; Edelmann E; Castrén E; Gottmann K; Marie H; Lessmann V
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255764
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer's disease mice.
Alves S; Churlaud G; Audrain M; Michaelsen-Preusse K; Fol R; Souchet B; Braudeau J; Korte M; Klatzmann D; Cartier N
Brain; 2017 Mar; 140(3):826-842. PubMed ID: 28003243
[TBL] [Abstract][Full Text] [Related]
13. FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders.
Kiyota T; Ingraham KL; Jacobsen MT; Xiong H; Ikezu T
Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1339-48. PubMed ID: 22042871
[TBL] [Abstract][Full Text] [Related]
14. Transgenic mice with chronic NGF deprivation and Alzheimer's disease-like pathology display hippocampal region-specific impairments in short- and long-term plasticities.
Houeland G; Romani A; Marchetti C; Amato G; Capsoni S; Cattaneo A; Marie H
J Neurosci; 2010 Sep; 30(39):13089-94. PubMed ID: 20881126
[TBL] [Abstract][Full Text] [Related]
15. Enhanced memory consolidation in mice lacking the circadian modulators Sharp1 and -2 caused by elevated Igf2 signaling in the cortex.
Shahmoradi A; Radyushkin K; Rossner MJ
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3582-9. PubMed ID: 26100875
[TBL] [Abstract][Full Text] [Related]
16. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways.
Stein TD; Johnson JA
J Neurosci; 2002 Sep; 22(17):7380-8. PubMed ID: 12196559
[TBL] [Abstract][Full Text] [Related]
17. Caspase-2 cleavage of tau reversibly impairs memory.
Zhao X; Kotilinek LA; Smith B; Hlynialuk C; Zahs K; Ramsden M; Cleary J; Ashe KH
Nat Med; 2016 Nov; 22(11):1268-1276. PubMed ID: 27723722
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor 1 gene transfer for sporadic Alzheimer's disease: New evidence for trophic factor mediated hippocampal neuronal and synaptic recovery-based behavior improvement.
Zappa Villar MF; López Hanotte J; Crespo R; Pardo J; Reggiani PC
Hippocampus; 2021 Oct; 31(10):1137-1153. PubMed ID: 34324234
[TBL] [Abstract][Full Text] [Related]
19. A Novel MicroRNA-124/PTPN1 Signal Pathway Mediates Synaptic and Memory Deficits in Alzheimer's Disease.
Wang X; Liu D; Huang HZ; Wang ZH; Hou TY; Yang X; Pang P; Wei N; Zhou YF; Dupras MJ; Calon F; Wang YT; Man HY; Chen JG; Wang JZ; Hébert SS; Lu Y; Zhu LQ
Biol Psychiatry; 2018 Mar; 83(5):395-405. PubMed ID: 28965984
[TBL] [Abstract][Full Text] [Related]
20. RanBP9 overexpression accelerates loss of dendritic spines in a mouse model of Alzheimer's disease.
Wang R; Palavicini JP; Wang H; Maiti P; Bianchi E; Xu S; Lloyd BN; Dawson-Scully K; Kang DE; Lakshmana MK
Neurobiol Dis; 2014 Sep; 69():169-79. PubMed ID: 24892886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
